Clinical Trials in Gastroesophageal Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Clinical Research of Cancer".
Deadline for manuscript submissions: closed (23 February 2024) | Viewed by 3608
Special Issue Editor
Special Issue Information
Dear Colleagues,
Clinical trials underpin modern clinical practice for patients with gastroesophageal cancer. Multimodality therapy remains the mainstay of treatment for gastroesophageal cancer, with the evidence for its effectiveness coming largely from recent clinical trials integrating immunotherapy into the therapeutic repertoire. However, clinical trials of gastroesophageal cancer are notoriously challenging, as several pitfalls are associated with the design and delivery of these trials in a complex cohort of patients with a highly heterogenous tumor. The field is developing even further as we move towards trials with a greater degree of international collaboration that include the introduction of novel endpoints, surgical and radiological quality assurance and the utilization of machine learning algorithms, warranting a Special Issue in this area.
We invite the submission of papers detailing clinical trials in gastroesophageal cancer, along with articles in the following areas:
- Clinical trials concerning the diagnosis or management of gastroesophageal cancer.
- Challenges to undertaking trials in gastroesophageal cancer.
- Quality assurance of interventions concerning gastroesophageal cancer.
- Future prospects for clinical trials of gastroesophageal cancer.
Dr. Sheraz Rehan Markar
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- esophageal cancer
- gastric cancer
- oncology
- surgery
- clinical trials
- diagnostics
- treatment